CA19-9 Cancer Antigen

This product is available for purchase offline. Please contact us to discuss your requirements.
CA19-9 is elevated in blood, primarily in patients with carcinoma of the gastro-intestinal tract. Higher levels are more likely to be due to malignancy than lower levels, however very high levels are occasionally seen in patients with benign conditions such as cirrhosis. CA19-9 is not sufficiently specific for use as a screening test, its greatest usefulness is with pancreatic cancer compared with pancreatitis. The specificity for pancreatic cancer increases with increasing levels, high levels showing a specificity of >97%.
More Information
Abbreviation CA19-9
Applications Biosensors, Clinical Chemistry, Control Manufacture, ELISA, Lateral Flow, Life Science
Disease Area Tumour Markers
Keywords CA19-9, CA19-9 antigen, cancer antigen, human
Molecular Weight 100000 Da
Presentation Matrix PBS azide buffer / NaCl
Product Category Recombinant Antigens
Purity/Grade Low Cross Contamination
Recommended Use


Shipping Recommendation -20°C
Source Human Cell line
Storage -20°C
Copyright © 2019 BBI Solutions. All rights reserved. Designed trademarks and brands are the property of their respective owners. BBIUS